Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE

FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE

Standard Dose
20MG;12.5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 090228 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE Form and strength TABLET;ORAL - 20MG;12.5MG Sponsor INVAGEN PHARMS Submission history Latest submission status date: 2020-08-20 00:00:00.

Structured Monograph

Clinical summary

Approval overview FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 090228 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient FOSINOPRIL SODIUM; HYDROCHLOROTHIAZIDE Form and strength TABLET;ORAL - 20MG;12.5MG Sponsor INVAGEN PHARMS Submission history Latest submission status date: 2020-08-20 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.